1[1]Granger JP, Alberola AM, Salazar FJ, et al. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs[J].J Cardiovasc Pharmacol,1992,20:S160-S162.
2[2]Zata R, DeNucci G. Effect of acute nitric oxide inhibition on rat glomerular microcirculation[J].Am J physiol,1991,261:F360-F363.
3[3]Qiu CB, Engels k, Samsell, et al. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade[J]. Hypertension,1995,25:61-66.
4[4]Docherty NG, Perez-Barriocanal F, Balboa NE,et al. Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney[J]. Ren Fail, 2002,24(4):391-406.
5[5]Kashiwagi M, Shinozaki M. Hirakata H, et al. Locally activated renin-angiotensin system associated with TGF-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats[J].J AM Soc Nephrol,2000,11:616-624.
7[7]Taol MW, Brenner BM. Renoprotective benefits of RAS inhibition: From ACEI to angiotensinⅡ antagonist[J]. kidney Int, 2000,57:1803-1817.
8[8]Soon Won Hong, Motohide Isono, Sheldon Chen, et al. Increased glomerular and tubular expression of transforming growth Factor-β1, its type Ⅱ receptor, and activation of the Smad signaling pathway in the db/db mouse[J].Am J Pathology, 2001,158:1653-1663.
9[9]Dong Cheol Han, Motohide Isono, Sheldon Chen, et al. Leptin stimulates type I collagen production in db/db mesangial cells:Glucose uptake and TGF-β1 type Ⅱ receptor expression[J]. Kidney Int,2001,59(4):1315.
10[10]Isono M, Chen S, Hong SW, et al. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates GF-beta-induced fibronectin in mesangial cells[J]. Biochem Biophys Res Commun,2002,296(5):1356-65.
1Kon Y.Local renin-angiotensin system:especially in coag-ulating glands of mice[J].Arch Histol Cytol,1996,59(5):399-420.
2Tharauxp L,Chatziantoniou C,Fakhouri F,et al.Angio-tensin II activates collagen I gene through a mechanism in-volving the MAP/ER kinase pathway[J].Hypertention,2000,36(3):330-336.
3Kashiwagi M,Shinozaki M,Hirakata H,et al.Locally acti-vated renin-angiotensin system associated with TGF-beta1as a major factor for renal injury induced by chronic inhi-bition of nitric oxide synthase in rats[J].J Am Soc Neph-rol,2000,11(4):616-624.
4Lavoie P,Robitaille G,Agaharazii M,et al.Involvement oftransforming growth factor-beta in the pathogenesis of hy-pertension in rats with chronic renal failure[J].Hyper-tens,2004,22(Suppl):80.
5PhilIips MI,Kagiyama S.Angiotensin II as a pro-inflamma-tory mediator[J].Curr Opin Investig Drugs,2002,3(4):569-577.
6Xin C,Ren S,Eberhardt W,et al.The immunomodulatorFTY720 and its phosphorylated derivative activate theSmad signalling cascade and upregulate connective tissuegrowth factor and collagen type IV expression in renal me-sangial cells[J].Br J Pharmacol,2006,147(2):164-174.
7Patel R,Nagueh SF,Tsybouleva N,et al.Simvastatin in-duces regression of cardiac hypertrophy and fibrosis andimproves cardiac function in a transgenic rabbit model ofhuman hypertrophic cardiomyopathy[J].Circulation,2001,104(3):317-324.
8Borghi C,Prandin MG,Costa FV,et al.Use of statins andblood pressure control in treated hypertensive patients withhypercholesterolemia[J].J Cardiovasc Pharmacol,2000,35(4):549-555.
9Ichiki T,Takeda K,Tokunou T,et al.Downregulation ofangiotensinⅡtype 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascularsmooth muscle cells[J].Arterioscler Thromb Vasc Biol,2001,21(12):1896-1901.
10Herman DB,Struening EL,Barrow SM.Lovastatin pre-vents glomerulosclerosis in streptozotozin-induced diabeticuninephrectomized rats[J].Hosp Community Psychiatry,1993,44(12):1181-1183.
